US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist

51.170
+0.330+0.65%

Close Nov 29 13:00 ET

51.180
+0.010+0.02%

Post 16:32 ET

4.37BMarket Cap-18340P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 10.544M	--
--	2024/Q4	-- / 7.379M	--
--	2024/Q3	602.000K / 7.132M	--
--	2024/Q2	517.000K / 13.613M	--
--	2024/Q1	504.000K / 26.494M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 10.544M--

--2024/Q4-- / 7.379M--

--2024/Q3602.000K / 7.132M--

--2024/Q2517.000K / 13.613M--

--2024/Q1504.000K / 26.494M--

Unlock Free Earnings Estimates

Open Account

CRISPR Therapeutics Earnings Reports

CRISPR Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5 09:16 ET

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 5 09:06 ET

CRISPR Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 5 16:13 ET

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 5 16:09 ET

Analyst Rating

Updated: Nov 30, 2024

Buy

Buy
52.94%
Hold
35.29%
Sell
11.77%

Price Target

No Data

Heat List

Overall

No Data